Filed: 7/26/2023ACC: 0001846639-23-000005
📋 What this filing means
VALLIANCE ASSET MANAGEMENT LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $6.26M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$6.26M
Total AUM (reported)
2.80M
Total Shares
Allocation by class
SPONSORED ADS$4.00M63.9%
ORDINARY SHARES$2.22M35.4%
*W EXP 03/15/202$35.3K0.6%
*W EXP 02/04/202$8.0K0.1%
Portfolio Concentration
Top 3$6.25M99.9%
4–10$8.0K0.1%
Top 3 weight
99.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.80M
Sole
Full voting authority
2.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
TAIWAN SEMICONDUCTOR MFG LTD
SOLEShares39.63K
TypeSH
Market value$4.00M
63.89%
Sole
39.63K
Shared
0.00
None
0.00
YS BIOPHARMA CO LTD
SOLEShares1.61M
TypeSH
Market value$2.22M
35.42%
Sole
1.61M
Shared
0.00
None
0.00
YS BIOPHARMA CO LTD
SOLEShares750K
TypeSH
Market value$35.3K
0.56%
Sole
750K
Shared
0.00
None
0.00
HH&L ACQUISITION CO
SOLEShares400K
TypeSH
Market value$8.0K
0.13%
Sole
400K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TAIWAN SEMICONDUCTOR MFG LTDSOLE | SPONSORED ADS | 39.63K | SH | $4.00M 63.89% | 39.63K | 0.00 | 0.00 |
YS BIOPHARMA CO LTDSOLE | ORDINARY SHARES | 1.61M | SH | $2.22M 35.42% | 1.61M | 0.00 | 0.00 |
YS BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 750K | SH | $35.3K 0.56% | 750K | 0.00 | 0.00 |
HH&L ACQUISITION COSOLE | *W EXP 02/04/202 | 400K | SH | $8.0K 0.13% | 400K | 0.00 | 0.00 |